PRODUCTS
SERVICES
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
2.57
2 yrs 5 m
0%
741.34 Crs
NIL
Mid Growth
9.11
SIP 100 & Lumpsum 500
BSE HEALTH CARE - TRI
Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal
Investors understand that their principal will be at very high risk